ED
NOV icon

Exane Derivatives’s NOV NOV Stock Holding History

Exane Derivatives’s Portfolio NOV Stock Details NOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1
Closed -$43 – 719
2018
Q3 		$43 Hold
1
– – ﹤0.01% 648
2018
Q2 		$44 Hold
1
– – ﹤0.01% 641
2018
Q1 		$36 Sell
1
-32
-97% -$1.17K ﹤0.01% 582
2017
Q4 		$1.19K Sell
33
-3,303
-99% -$112K ﹤0.01% 478
2017
Q3 		$119K Sell
3,336
-649
-16% -$21.2K 0.02% 240
2017
Q2 		$131K Buy
3,985
+2,121
+114% +$73.2K 0.03% 243
2017
Q1 		$74.7K Buy
1,864
+384
+26% +$15K 0.02% 244
2016
Q4 		$55.4K Buy
1,480
+15
+1% +$546 0.01% 294
2016
Q3 		$53.8K Buy
1,465
+75
+5% +$2.52K 0.01% 294
2016
Q2 		$46.8K Sell
1,390
-307
-18% -$9.86K 0.01% 279
2016
Q1 		$52.8K Hold
1,697
– – 0.01% 301
2015
Q4 		$56.8K Hold
1,697
– – 0.01% 253
2015
Q3 		$63.9K Buy
1,697
+522
+44% +$21.4K 0.01% 251
2015
Q2 		$56.7K Hold
1,175
– – 0.01% 279
2015
Q1 		$58.7K Buy
1,175
+24
+2% +$1.3K 0.01% 305
2014
Q4 		$75.4K Buy
+1,151
New +$80.2K 0.01% 306

Other funds holding NOV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
VVP
Vulcan Value Partners Birmingham, Alabama $3.77B AUM 9.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Exane Derivatives's NOV Position: Q4 2018 in Review

Exane Derivatives sold out of NOV (NOV) in Q4 2018, closing a stake of 1 share — an estimated $43 sold.

Exane Derivatives first reported a position in NOV in Q4 2014 and held it in 16 quarters. The position peaked at $131K in Q2 2017. 548 funds tracked by Wall St. Rank hold NOV as of Q4 2018.

  • Exane Derivatives reported no remaining NOV position as of Q4 2018 after selling out during the quarter.
  • Exane Derivatives sold 1 NOV share in Q4 2018, an estimated $43.
  • Exane Derivatives first reported a position in NOV in Q4 2014 and held it in 16 quarters.
  • Exane Derivatives's NOV position peaked at $131K in Q2 2017.
  • 548 funds tracked by Wall St. Rank held NOV as of Q4 2018.

Based on Exane Derivatives's 13F filing for Q4 2018, filed 31 Jan 2019.